ETFs & Funds
with continued high short interest. Of all the stocks to short, this is one of the worst. Solid data. Potential to go up 10x quickly
i like where your heads at ...i would like to see the chart mirror that of
Th-302 could be the breakthru drug that oncologists have been looking for. By targeting hypoxic niche, kills CSCs that promotes recurrence
Hypoxic CSCs r the 'untouchables' in oncology. Must b killed, but cannot get to them.
Add a reply...
Latest StockTalks »
people get THLD breaking news and analysis by email alert.
Get email alerts on THLD »
Threshold Pharmaceuticals, Inc.
Get latest price
From other sites
Threshold Pharmaceuticals’ stock plunges after drug trial disappoints
at MarketWatch.com (Dec 7, 2015)
Threshold Pharmaceuticals : Announces Presentation and Webcast at the Stifel 2015 Healthcare Conference
at 4-traders.com (Nov 11, 2015)
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
at Benzinga.com (Dec 31, 2014)
Stocks to Watch: WFC, TSLA, NFLX & More
at CNBC.com (Sep 17, 2012)
Movers & Shakers: Monday’s biggest gaining and declining stocks
at MarketWatch.com (Sep 17, 2012)